Financing innovation in China

How Yabao Pharma plans to access innovative R&D through newco Suzhou Yabao

Yabao Pharmaceutical Group Co. Ltd. is seeking VCs to join it in financing a new spinout that has aspirations to participate in global development of novel drugs. Newco Suzhou Yabao Pharmaceutical R&D Co. Ltd. is in-licensing Chinese rights and doing early development work under global quality standards with the aim to produce data a third party can use to jump-start global development.

Suzhou Yabao was formed last year as the innovative R&D arm of Yabao, a generic and traditional Chinese medicine company that is looking to

Read the full 861 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE